Skip to main content

Table 1 Sample information and sequencing results

From: Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid

Specimen

Sex

Age

Diagnosis

Duration of disease

ALSFRS-R

Mapped reads

NH1

M

62

Healthy

N.A.

N.A.

60,623,044

NH2

M

57

Healthy

N.A.

N.A.

40,284,207

NH3

M

60

Healthy

N.A.

N.A.

54,089,758

NH4

M

56

Healthy

N.A.

N.A.

30,168,826

ALS1

M

57

sALS

1 year

45

23,718,245

ALS2

M

55

sALS

0.5 year

43

23,604,092

ALS3

M

51

sALS

5 years

42

44,024,882

ALS4

M

67

sALS

2 years

41

21,196,954

  1. Background information on donors of cerebrospinal fluid (CSF) specimens is summarized. Additionally, read numbers of those successfully mapped to human genome reference B37.3 in exoRNA-seq are also shown. NH normal healthy, sALS sporadic ALS, N.A., represents not applicable